Euroopa Liit -
slovaki -
EMA (European Medicines Agency)
tadalafil mylan
mylan pharmaceuticals limited - tadalafil - erektilná dysfunkcia - urologika - liečba erektilnej dysfunkcie u dospelých samcov. aby bol tadalafil účinný, vyžaduje sa sexuálna stimulácia. tadalafil mylan nie je indikovaný na použitie u žien.
Slovakkia -
slovaki -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
terbinafin mylan 250 mg
mylan ireland limited, Írsko - terbinafín - 26 - antimycotica (lokÁlne a celkovÉ)
Slovakkia -
slovaki -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
paclitaxel mylan 6 mg/ml
mylan s.a.s., francúzsko - paklitaxel - 44 - cytostatica
Slovakkia -
slovaki -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
pantomyl 40 mg
viatris limited, Írsko - pantoprazol - 09 - antacida (vrÁtane antiulcerosnych lieČiv)
Slovakkia -
slovaki -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
pantoprazol mylan 20 mg
mylan ireland limited, Írsko - pantoprazol - 09 - antacida (vrÁtane antiulcerosnych lieČiv)
Slovakkia -
slovaki -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
metformin teva xr 1000 mg
teva b.v., holandsko - metformín - 18 - antidiabetica (vrÁtane inzulÍnu)
Slovakkia -
slovaki -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
metformin teva xr 750 mg
teva b.v., holandsko - metformín - 18 - antidiabetica (vrÁtane inzulÍnu)
Slovakkia -
slovaki -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
metformin teva xr 500 mg
teva b.v., holandsko - metformín - 18 - antidiabetica (vrÁtane inzulÍnu)
Euroopa Liit -
slovaki -
EMA (European Medicines Agency)
pirfenidone viatris
viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - imunosupresíva - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).
Euroopa Liit -
slovaki -
EMA (European Medicines Agency)
dapagliflozin viatris
viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - lieky používané pri cukrovke - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 a 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.